glp-1 safety and side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy Applications for Gastrointestinal Disease Treatment Part 2 of a 3-Part

gut barrier function

GLP-1s like Ozempic, Wegovy, and Mounjaro have gained a lot of media attention for weight loss, but how do these weight-loss injections work

Most GLP-1 users experience temporary nausea and digestive changes that peak in the first 24 weeks, then gradually fade as the body adjusts

A 2023 report found 68% percent of Virginia's adults are overweight or obese

A New Indication for Semaglutide (Wegovy) The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease (CVD) and either obesity or overweight

Expert periodontics care for gum disease prevention and treatment